Guillermo Amescua is an Ophthalmology physician affiliated with University of Miami. OpenAlex indexes 186 publications with 3,281 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1475 NW 12th Ave
Miami, FL 331361002
Telephone
305-243-2020Provider last certified this registry record 3 Apr 2025.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- W. L. Gore & Associates, Inc.Program year202510 payments$10,305openpaymentsdata.cms.gov ↗
- Carl Zeiss Meditec, Inc.Program year20252 payments
- Oyster Point Pharma, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
68.6%Corticosteroid37.7%Prednisolone Acetate93%Fluorometholone7%Part D≥327 patientsPolymyxin-class Antibacterial16.8%Polymyxin B Sul-Trimethoprim100%Part D≥212 patients+ 5 more classes in this area
Musculoskeletal
12.7%Cyclooxygenase Inhibitor12.7%Ketorolac Tromethamine100%Part D≥166 patientsAnti-infectives
9.7%Fluoroquinolone Antibacterial4.4%Moxifloxacin100%Part D≥27 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor3.2%Valacyclovir100%Part D≥23 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Carlos Singer
University of Miami
Kara Cavuoto, MD
University of Miami
Sixto Arias, MD
University of Miami
Richard Kardon, DO
University of Miami
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Richard Spaide, MD
Vitreous Retina Macula Consultants of New York
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”